Abstract
Ten new hybrids were designed and synthesized, their chemical structures were confirmed through spectral and elemental analysis. The new hybrids were screened against lung, breast and liver cancer cell lines (A549, MCF7 and Hep3B), in addition to normal fibroblast cells. Compound 13a was the most active and selective one on the lung cancer cell line (A549), its IC50 and S.I. values were 2.4 µM and 83.2, respectively. Compound 14b was active on MCF7 with the best selectivity towards this cell line. The new derivatives were screened for their inhibitory activity against COX enzymes, the obtained results revealed that compound 13a and 14b were more active inhibitors for COX-2 than celecoxib. This finding encourages us to consider COX-2 inhibitory activity as a proposed mechanism for their anticancer activity.
Similar content being viewed by others
References
J.C. Otto, W.L. Smith, J. Lipid Mediat. Cell Signal. 12(2–3), 139 (1995)
G. Dannhardt, W. Kiefer, Eur. J. Med. Chem. 36(2), 109 (2001)
J.S. Carter, Expert Opin. Ther. Pat. 8(1), 21 (1998)
G. Gasparini, R. Longo, R. Sarmiento, A. Morabito, Lancet Oncol. 4, 605 (2003)
M.J. Thun, S.J. Henley, C. Patrono, J. Natl. Cancer Inst. 94, 252 (2002)
R.A. Soslow, A.J. Dannenberg, D. Rush, B.M. Woerner, K.N. Khan, J. Masferrer, A.T. Koki, Cancer. 89, 2637 (2000)
X.H. Liu, A. Kirschenbaum, S. Yao, R. Lee, J.F. Holland, A.C. Levine, J. Urol. 164, 820 (2000)
A.L. Hsu, T.T. Ching, D.S. Wang, X. Song, V.M. Rangnekar, C.S. Chen, J. Biol Chem. 275, 11397 (2000)
Y. Liu, S.R. Cox, T. Morita, S. Kourembanas, Circ. Res. 77, 638 (1995)
S.F. Yan, I. Tritto, D. Pinsky, H. Liao, J. Huang, G. Fuller, J. Brett, L. May, D. Stern, J Biol. Chem. 270, 11463 (1995)
M. Karakurum, R. Shreeniwas, J. Chen, D. Pinsky, S.D. Yan, M. Anderson, K. Sunouchi, J. Major, T. Hamilton, K. Kuwabara, J Clin Invest. 93, 1564 (1994)
H. Tian, S.L. McKnight, D.W. Russel, Genes Dev. 11, 72 (1997)
A.T. Koki, J.L. Masferrer, Cancer Control. 9(2), 28 (2002)
G. Steinbach, P.M. Lynch, R.K. Phillips, M.H. Wallace, E. Hawk, G.B. Gordon, N. Wakabayashi, B. Saunders, Y. Shen, T. Fujimura, L.K. Su, B. Levin, N. Engl. J. Med. 342, 1946 (2000)
J.H. Farley, V. Truong, E. Goo, C. Uyehara, C. Belnap, W.I. Larsen, Gynecol Oncol. 103, 425 (2006)
G. Hawcroft, M. D’Amico, C. Albanese, A.F. Markham, R.G. Pestell, M.A. Hull, Carcinogenesis. 23, 107 (2002)
R.S. Keri, K. Chand, T. Ramakrishnappa, B.M. Nagaraja, Arch. Pharm. Chem. Life Sci. 348, 299 (2015)
C.D. Fan, B.X. Zhao, F. Wei, G.H. Zhang, W.L. Dong, J.Y. Miao, Bioorg Med Chem Lett. 18, 3860 (2008)
P. Malhotra, S. Pattan, A.P. Nikalje, Int J Pharm Pharm sci. 2(2), 21 (2010)
A. Chauhana, P.K. Sharma, N. Kaushik, N. Kumar, Int J Pharm Pharm Sci. 3, 166 (2011)
R. Fioravanti, A. Bolasco, F. Manna, F. Rossi, F. Orallo, F. Ortuso, S. Alcaro, R. Cirilli, Eur J Med Chem. 45, 6135 (2010)
R. Paramashivappa, P. Phanikumar, P. Subbarao, A. Srinivasarao, Bioorg Med Chem Lett. 13, 657 (2003)
M.A. Abdelgawad, A. Belal, H.A. Omar, L. Hegazy, M.E. Rateb, Arch. Pharm. Chem. Life Sci. 346, 534 (2013)
S. Nagarjan, G. Crescenzo, D. Getman, H. Lu, J. Sikorski, J. Walker, J. McDonald, K. Houseman, G. Kocan, N. Kishore, P. Mehta, C. Shippy, L. Blystone, Bioorg. Med. Chem. 11, 4769 (2003)
R.S. Keri, M.R. Patil, S.A. Patil, S. Budagumpi, Eur J Med Chem. 89, 207 (2015)
M.A. Abdelgawad, A. Belal, O.M. Ahmed, J Chem and Pharm Res. 5(2), 318 (2013)
G.H. Jin, H. Li, S. An, J.-H. Ryu, R. Jeon, Bioorg & Med Chem Lett. 20, 6199 (2010)
K. Seth, S.K. Garg, R. Kumar, P. Purohit, V.S. Meena, R. Goyal, U.C. Banerjee, A.K. Chakraborti, Med. Chem. Lett. 5, 512 (2014)
M.S. Chua, D.F. Shi, S. Wrigley, T.D. Bradshaw, I. Hutchinson, P.N. Shaw, D.A. Barett, L.A. Stanley, M.F.G. Stevens, J. Med. Chem. 42, 381 (1999)
P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, M.R.J. Boyd, Nat. Cancer Inst. 82, 1107 (1990)
N.M. Bhatia, K.R. Mahadik, M.S. Bhatia, Daru. J Pharm. Sci. 18, 230 (2010)
Acknowledgements
Authors are grateful to Dr. Ahmed B. M. Mehany, Zoology Department, Faculty of Science, Al-Azhar university, Egypt, for his help in performing cytotoxicity for the new compounds.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Belal, A., Abdelgawad, M.A. New benzothiazole/benzoxazole-pyrazole hybrids with potential as COX inhibitors: design, synthesis and anticancer activity evaluation. Res Chem Intermed 43, 3859–3872 (2017). https://doi.org/10.1007/s11164-016-2851-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-016-2851-x